Vyant Bio Overview
- Year Founded
-
1999
- Status
-
Out of Business
- Employees
-
85
- Latest Deal Type
-
Out of Business
Vyant Bio General Information
Description
Provider of biotechnology and drug discovery services intended to incorporate human biology, engineering and data science to improve drug delivery.
Contact Information
Website
www.vyantbio.comCorporate Office
- 2 Executive Campus, 2370 State Route 70 West
- Suite 310
- Cherry Hill, NJ 08002-4102
- United States
Corporate Office
- 2 Executive Campus, 2370 State Route 70 West
- Suite 310
- Cherry Hill, NJ 08002-4102
- United States
Vyant Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Out of Business | 26-Dec-2023 | Completed | Out of Business | |||
| 11. PIPE | 28-Mar-2022 | Completed | Generating Revenue | |||
| 10. PIPE | 01-Feb-2021 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Open Market | 21-Dec-2017 | Completed | Generating Revenue | |||
| 8. PIPE | 12-Dec-2017 | Completed | Generating Revenue | |||
| 7. PIPE | 09-Sep-2016 | Completed | Generating Revenue | |||
| 6. 2PO | 09-Nov-2015 | Completed | Generating Revenue | |||
| 5. 2PO | 14-Aug-2013 | Completed | Generating Revenue | |||
| 4. IPO | 05-Apr-2013 | $6M | $19.1M | Completed | Generating Revenue | |
| 3. Later Stage VC (Series B) | 01-Nov-2010 | $9.1M | $13.1M | Completed | Generating Revenue |
Vyant Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A1 | ||||||||
| Series A | 588,000 | $0.000100 | $8.46 | $8.46 | $8.46 | 3.19% |
Vyant Bio Comparisons
Industry
Financing
Details
Vyant Bio Competitors (40)
One of Vyant Bio’s 40 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Personalis | Formerly VC-backed | Fremont, CA | ||||
| Caris Life Sciences | Formerly PE-Backed | Irving, TX | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Dynavax Technologies | Formerly VC-backed | Emeryville, CA |
Vyant Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vyant Bio Patents
Vyant Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160130665-A1 | Prognostic methods and systems for chronic lymphocytic leukemia | Inactive | 11-Nov-2014 | ||
| CA-2901543-A1 | Methods and tools for the diagnosis and prognosis of urogenital cancers | Inactive | 15-Feb-2013 | ||
| EP-2956551-A1 | Methods and tools for the diagnosis and prognosis of urogenital cancers | Inactive | 15-Feb-2013 | ||
| US-20140235458-A1 | Methods and tools for the diagnosis and prognosis of urogenital cancers | Inactive | 15-Feb-2013 | ||
| US-20120202200-A1 | Methods for detecting human papilloma virus-associated cancers | Active | 08-Sep-2010 | C12Q1/708 |
Vyant Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vyant Bio Acquisitions (5)
Vyant Bio’s most recent deal was a Merger/Acquisition with StemoniX for . The deal was made on 30-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| StemoniX | 30-Mar-2021 | Merger/Acquisition | Biotechnology | ||
| VivoPharm | 15-Aug-2017 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Response Genetics | 09-Oct-2015 | Merger/Acquisition | Diagnostic Equipment | ||
| Gentris | 16-Jul-2014 | Merger/Acquisition | Practice Management (Healthcare) | ||
| Cancer Genetics India | 15-May-2014 | Merger/Acquisition | Laboratory Services (Healthcare) |
Vyant Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Internet Software and Services
Subindustry
Rank
Percentile
Vyant Bio FAQs
-
When was Vyant Bio founded?
Vyant Bio was founded in 1999.
-
Where is Vyant Bio headquartered?
Vyant Bio is headquartered in Cherry Hill, NJ.
-
What is the size of Vyant Bio?
Vyant Bio has 85 total employees.
-
What industry is Vyant Bio in?
Vyant Bio’s primary industry is Biotechnology.
-
Is Vyant Bio a private or public company?
Vyant Bio is a Private company.
-
What is Vyant Bio’s current revenue?
The current revenue for Vyant Bio is .
-
How much funding has Vyant Bio raised over time?
Vyant Bio has raised $83.1M.
-
Who are Vyant Bio’s competitors?
Inovio Pharmaceuticals, Personalis, Caris Life Sciences, Agenus, and Dynavax Technologies are some of the 40 competitors of Vyant Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
